Diagnostic Testing for Familial Pancreatitis
description
Transcript of Diagnostic Testing for Familial Pancreatitis
![Page 1: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/1.jpg)
Diagnostic Testing for Familial Pancreatitis
Emma McCarthyClinical Scientist
Merseyside & Cheshire Regional Molecular Genetics Laboratory
![Page 2: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/2.jpg)
Aims
• Overview of pancreatitis both hereditary and idiopathic
• Genes involved & diagnostic service
• PRSS1 dosage analysis
![Page 3: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/3.jpg)
![Page 4: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/4.jpg)
Pancreatitis
• Inflammatory disease – Severe abdominal pain– Nausea– Vomiting fever– Acute or chronic
• Premature activation digestive enzymes
• Common triggers– Excessive alcohol consumption– Smoking– Gallstones
![Page 5: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/5.jpg)
TRYPSINOGEN
TRYPSIN
AUTODIGESTION
CHRONIC PANCREATITIS
PERMANENT LOSS OF FUNCTION
DIABETES / PANCREATIC CANCER
multiple attacks
premature activation enzymes
activation
irreversible scarring
advanced stages
![Page 6: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/6.jpg)
Reproduced from: Rosendahl et al. Orphanet Journal of Rare Diseases 2007 2:1
![Page 7: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/7.jpg)
Diagnostic service
• PRSS1– Fluorescent sequencing exons 2 + 3
• SPINK1– p.N34S mutation (pyrosequencing)
• CFTR– 28 mutations (Elucigene CFHT)
• EUROPAC: www.liv.ac.uk/surgery/europac.html
![Page 8: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/8.jpg)
Hereditary Pancreatitis (HP)
• Autosomal dominant
• Reduced penetrance
• Childhood:– recurrent episodes acute pancreatitis
• Adulthood:– chronic pancreatitis
• Mutations of cationic trypsinogen gene (PRSS1)
![Page 9: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/9.jpg)
Cationic Trypsinogen
• PRSS1 gene (protease serine 1)
• Trypsin– Activates digestive enzymes– Self regulating
• Autocatalytic activation• Feedback inhibition - cleaves at Arg122
• R122H mutation - “super trypsin”
![Page 10: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/10.jpg)
PRSS1 PRSS2TRY5 TRY7TRY6 TCRTCR
4kb initial PCR product
![Page 11: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/11.jpg)
N29I L41L C48C
p.N29I c.86A>T
p.C48C c.144T>C
p.L41L c.121C>T
p.N54S c.161A>G
p.V59V c.177A>G
p.G62G c.186C>T
![Page 12: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/12.jpg)
Laboratory Data
• Prior 2007: – PCR / restriction digest - p.A16V, p.N29I, p.R122H
• Feb 2007: – fluorescent sequencing exons 2 & 3
• Pathogenic mutations detected - 7/77 (9.1%)• 2/77 unclassified variants • Total sequence changes identified - 9/77 (11.7%)
![Page 13: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/13.jpg)
Idiopathic Chronic Pancreatitis (ICP)
• 30% pancreatitis cases - unknown cause
• Susceptibility genes:– SPINK1 - Serine Protease Inhibitor Kazal type 1 – CFTR – mild mutations; ICP specific mutations?– ?polygenic model
![Page 14: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/14.jpg)
SPINK1
• Inhibits 20% pancreatic trypsin
• p.N34S mutation– 22% ICP patients– 2.5% general population– ?disease modifier
![Page 15: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/15.jpg)
SPINK1 Analysis
• Pyrosequencing assay– c.101A>G; p.N34S
• 9/60 mutation carriers– 0/8 CFTR mutations
• no CF testing on 1 positive case
Normal
2 copies N34S
1 copy N34S
![Page 16: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/16.jpg)
PRSS1 Dosage Analysis
• Triplication of trypsinogen locus reported– Le Maréchal et al., Nature Genetics 2006; 38:1372-4
• Fluorescent dosage analysis PRSS1 exon 1
• 40 families (EUROPAC)
• Duplication in mother & daughter
![Page 17: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/17.jpg)
Normal Sample
Proband
PRSS2 exon 4
Proband
Normal Sample
PRSS1
![Page 18: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/18.jpg)
Pedigree
DUP
DUP
DUP
DUPDUP
Awaiting sample
nmdnmd
nmd
44
72
51
21 19
70
22
7884
![Page 19: Diagnostic Testing for Familial Pancreatitis](https://reader033.fdocuments.us/reader033/viewer/2022051116/568152a2550346895dc0c92c/html5/thumbnails/19.jpg)
Acknowledgements
• Roger Mountford• Victoria Blake• DNA Laboratory Staff
• Chris Grocock• Bill Greenhalf• John P. Neoptolemos